Deepak Shenoy of capitalmind.in told CNBC-TV18, "In largecaps, we continue to like pharmaceutical space. We hold Sun Pharmaceutical Industries and Strides Arcolab. So we believe that with the dollar weakness as well, they are going to benefit in the long-term. Sun Pharma is the only stock that I would be purchasing among the largecaps at this point. Much of the rest seems like wait and watch for what is happening with the bond yields and a structural shift."
At 10:56 hrs Sun Pharmaceutical Industries was quoting at Rs 854.05, up Rs 21.90, or 2.63 percent. It has touched an intraday high of Rs 861 and an intraday low of Rs 827.50.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!